IBDEI0GD ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7590,1,5,0)
 ;;=5^DM Type I DM W/O Complications
 ;;^UTILITY(U,$J,358.3,7590,2)
 ;;=^33586
 ;;^UTILITY(U,$J,358.3,7591,0)
 ;;=272.0^^35^473^22
 ;;^UTILITY(U,$J,358.3,7591,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7591,1,4,0)
 ;;=4^272.0
 ;;^UTILITY(U,$J,358.3,7591,1,5,0)
 ;;=5^Hypercholesterolemia, Pure
 ;;^UTILITY(U,$J,358.3,7591,2)
 ;;=Hypercholesterolemia, Pure^59973
 ;;^UTILITY(U,$J,358.3,7592,0)
 ;;=272.1^^35^473^28
 ;;^UTILITY(U,$J,358.3,7592,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7592,1,4,0)
 ;;=4^272.1
 ;;^UTILITY(U,$J,358.3,7592,1,5,0)
 ;;=5^Hypertriglyceridemia, Pure
 ;;^UTILITY(U,$J,358.3,7592,2)
 ;;=Hypertriglyceridemia, Pure^101303
 ;;^UTILITY(U,$J,358.3,7593,0)
 ;;=272.2^^35^473^24
 ;;^UTILITY(U,$J,358.3,7593,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7593,1,4,0)
 ;;=4^272.2
 ;;^UTILITY(U,$J,358.3,7593,1,5,0)
 ;;=5^Hyperlipidemia, Mixed
 ;;^UTILITY(U,$J,358.3,7593,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,7594,0)
 ;;=275.42^^35^473^21
 ;;^UTILITY(U,$J,358.3,7594,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7594,1,4,0)
 ;;=4^275.42
 ;;^UTILITY(U,$J,358.3,7594,1,5,0)
 ;;=5^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,7594,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,7595,0)
 ;;=275.41^^35^473^29
 ;;^UTILITY(U,$J,358.3,7595,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7595,1,4,0)
 ;;=4^275.41
 ;;^UTILITY(U,$J,358.3,7595,1,5,0)
 ;;=5^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,7595,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,7596,0)
 ;;=276.7^^35^473^23
 ;;^UTILITY(U,$J,358.3,7596,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7596,1,4,0)
 ;;=4^276.7
 ;;^UTILITY(U,$J,358.3,7596,1,5,0)
 ;;=5^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,7596,2)
 ;;=^60042
 ;;^UTILITY(U,$J,358.3,7597,0)
 ;;=275.2^^35^473^19
 ;;^UTILITY(U,$J,358.3,7597,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7597,1,4,0)
 ;;=4^275.2
 ;;^UTILITY(U,$J,358.3,7597,1,5,0)
 ;;=5^Hyper Or Hypomagnesemia
 ;;^UTILITY(U,$J,358.3,7597,2)
 ;;=^35626
 ;;^UTILITY(U,$J,358.3,7598,0)
 ;;=276.0^^35^473^25
 ;;^UTILITY(U,$J,358.3,7598,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7598,1,4,0)
 ;;=4^276.0
 ;;^UTILITY(U,$J,358.3,7598,1,5,0)
 ;;=5^Hypernatremia
 ;;^UTILITY(U,$J,358.3,7598,2)
 ;;=^60144
 ;;^UTILITY(U,$J,358.3,7599,0)
 ;;=276.1^^35^473^32
 ;;^UTILITY(U,$J,358.3,7599,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7599,1,4,0)
 ;;=4^276.1
 ;;^UTILITY(U,$J,358.3,7599,1,5,0)
 ;;=5^Hyponatremia
 ;;^UTILITY(U,$J,358.3,7599,2)
 ;;=Hyponatremia^60722
 ;;^UTILITY(U,$J,358.3,7600,0)
 ;;=275.3^^35^473^20
 ;;^UTILITY(U,$J,358.3,7600,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7600,1,4,0)
 ;;=4^275.3
 ;;^UTILITY(U,$J,358.3,7600,1,5,0)
 ;;=5^Hyper Or Hypophosphatemia
 ;;^UTILITY(U,$J,358.3,7600,2)
 ;;=^93796
 ;;^UTILITY(U,$J,358.3,7601,0)
 ;;=240.0^^35^473^14
 ;;^UTILITY(U,$J,358.3,7601,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7601,1,4,0)
 ;;=4^240.0
 ;;^UTILITY(U,$J,358.3,7601,1,5,0)
 ;;=5^Goiter, Simple
 ;;^UTILITY(U,$J,358.3,7601,2)
 ;;=^259806
 ;;^UTILITY(U,$J,358.3,7602,0)
 ;;=241.1^^35^473^13
 ;;^UTILITY(U,$J,358.3,7602,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7602,1,4,0)
 ;;=4^241.1
 ;;^UTILITY(U,$J,358.3,7602,1,5,0)
 ;;=5^Goiter, Nontox, Multinod
 ;;^UTILITY(U,$J,358.3,7602,2)
 ;;=^267790
 ;;^UTILITY(U,$J,358.3,7603,0)
 ;;=241.0^^35^473^50
 ;;^UTILITY(U,$J,358.3,7603,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7603,1,4,0)
 ;;=4^241.0
 ;;^UTILITY(U,$J,358.3,7603,1,5,0)
 ;;=5^Thyroid Nodule, Nontoxic
 ;;^UTILITY(U,$J,358.3,7603,2)
 ;;=^83865
 ;;^UTILITY(U,$J,358.3,7604,0)
 ;;=242.00^^35^473^15
 ;;^UTILITY(U,$J,358.3,7604,1,0)
 ;;=^358.31IA^5^2
 ;;
 ;;$END ROU IBDEI0GD
